Skip to main content
OpenTrials
Completed

NCT Number: NCT04672538

Fontan Physiology Ventilation Strategy

This study will investigate the different tidal volume (Vt) strategies during a cardiac catheterization procedure to determine whether or not low or high Vt have an impact on cardiac output.

Research question: While maintaining the same minute ventilation/PaCO2, does higher Vt (10 cc/kg)/lower rate vs. lower Vt (6 cc/kg)/higher rate (maintaining consistent PEEP) result in improved cardiac output?

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, 15224, United States

About this study

The trial will be a randomized crossover design. The study cohort will be randomized (50/50) to begin with either low Vt or high Vt ventilation. After achieving steady state, initial cardiac output measurements will be made using a measured oxygen consumption (VO2) and the Fick principle, per routine clinical protocol. Following baseline assessment of cardiac output and hemodynamics (which is standard of care for all catheterization procedures), participants will be transitioned to the alternative ventilation modality (high Vt or low Vt). After a 5-minute equilibration period, oxygen saturations and VO2 measurements will be re-acquired, to determine cardiac output and hemodynamics in this second state.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of UPMC Children's Hospital of Pittsburgh that have Fontan physiology (single heart ventricle) that are presenting as outpatients to undergo a cardiac catheterization with general endotracheal anesthesia for purpose of diagnosis or interventional cath.
  • Parents and/or guardians willing to provide informed consent.

Exclusion criteria

  • Those unwilling to give consent and those patients who do not have Fontan physiology.
  • Any urgent/emergent catheterization procedure will be excluded.
  • Any Fontan patient having a cardiac catheterization under monitored anesthesia care (as opposed to general endotracheal anesthesia) will not be eligible.
  • Inability to undergo cardiac catheterization.
  • Pregnant women will be excluded.
  • < 6 weeks post-op from Fontan completion surgery
  • Same hospitalization as Fontan completion surgery
  • Intrinsic pulmonary disease which would be anticipated to impact study protocol / findings
  • Fontan completion surgery performed at age > 7 years

Treatment and study plan

Low Vt protocol

Procedure

Low Vt protocol - tidal volumes (Vt) 6 ml/kg, respiratory rate required for end tidal carbon dioxide (EtCO2) of 36-38 mmHg, PEEP 5 centimeter of water (cm-H20) , I:E ratio 1:2

High Vt protocol

Procedure

High Vt protocol - tidal volumes (Vt) 10 ml/kg, respiratory rate required for EtCO2 of 36-38 mm Hg, PEEP 5 cmH2O, I:E ratio 1:3.

Primary outcomes

  1. Cardiac Output

    Time frame: Measurements will occur at the 5-minute equilibration period into the ventilation strategy.

    The investigators will assess cardiac output using the Fink principle for each arm of randomization.

Secondary outcomes

  1. Pulmonary blood flow

    Time frame: Measurements will occur at the 5-minute equilibration period into the ventilation strategy.

    The investigators will compare blood flow in both arms.

  2. Systemic blood pressure

    Time frame: Measurements will occur at the 5-minute equilibration period into the ventilation strategy.

    The investigators will assess the vital sign in both intervention arms.

  3. Pulmonary arterial pressure

    Time frame: Measurements will occur at the 5-minute equilibration period into the ventilation strategy.

    The investigators will assess pressures in both intervention arms.

  4. Pulmonary vascular resistance

    Time frame: Measurements will occur at the 5-minute equilibration period into the ventilation strategy.

    Completed using pulmonary vascular resistance (PVR) equation from measurements obtained during the cardiac catheterization.

  5. Systemic vascular resistance

    Time frame: Measurements will occur at the 5-minute equilibration period into the ventilation strategy.

    This will be calculated using appropriate equations using measurement obtained during catheterization procedure.

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Registry information

Official study title

Impact of Fontan Ventilation Strategy on Cardiac Output: An Invasive Physiologic Cross-over Study

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Dec 17, 2020
Registry last updated
May 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.